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Shigella flexneri, the pathogen responsible for bacil-
lary dysentery, has evolved multiple strategies to
control the inflammatory response. Here, we show
that Shigella subverts the subcellular trafficking of
the intercellular adhesion molecule-1 (ICAM-1), a
key molecule in immune cell recruitment, in a mech-
anism dependent on the injected bacterial enzyme
IpgD and its product, the lipid mediator PI5P. Over-
expression of IpgD, but not a phosphatase dead
mutant, induced the internalization and the degrada-
tion of ICAM-1 in intestinal epithelial cells. Remark-
ably, addition of permeant PI5P reproduced IpgD
effects and led to the inhibition of neutrophil recruit-
ment. Finally, these results were confirmed in an
in vivo model of Shigella infection where IpgD-
dependent ICAM-1 internalization reduced neutro-
phil adhesion. In conclusion, we describe here an
immune evasion mechanism used by the pathogen
Shigella to divert the host cell trafficking machinery
in order to reduce immune cell recruitment.
INTRODUCTION
Phosphoinositides are key regulators of many aspects of cellular
functions controlling signal transduction pathways, cytoskeleton
remodeling, and vesicular trafficking (Di Paolo and De Camilli,
2006). Among the phosphoinositides family, phosphatidylinositol
5-phosphate (PI5P) is one of the least characterized members in
mammalian cells (Rameh et al., 1997). Although PI5P functions
are not fully revealed, it is nowconsidered a nuclear stress sensor
and a regulator of membrane dynamics (Viaud et al., 2014). The
lipid is present in lowbasal amounts in resting cells and increases
upon agonist stimulation (Morris et al., 2000) and stress condi-
tions such as osmotic shock or UV radiation (Jones et al., 2006;
Sbrissa et al., 2002). A robust increase in PI5P is also observed750 Cell Reports 14, 750–759, February 2, 2016 ª2016 The Authorsduring infection with the Gram-negative bacterium Shigella
flexneri (Niebuhr et al., 2002). In this context, PI5P is produced
by IpgD, one of the virulence factors injected by the type III secre-
tion system, a syringe-like complex that transfers bacterial pro-
teins directly into host cells (Puhar and Sansonetti, 2014). IpgD
is a phosphatidylinositol 4-phosphatase specifically hydrolyzing
PI(4,5)P2 to generate PI5P (Niebuhr et al., 2002). We have previ-
ously shown that PI5P is a key regulator of the trafficking of the
epidermal growth factor receptor (EGFR). Indeed, PI5P activates
the EGFR in a ligand-independent manner at the plasma mem-
brane (Ramel et al., 2011) and delays its degradation through
the recruitment of the adaptor TOM1 to signaling endosomes
(Boal et al., 2015), thereby leading to prolonged PI3K-Akt survival
signals in Shigella-infected cells (Pendaries et al., 2006).
Shigella flexneri is the causative agent of bacillary dysentery in
humans. After its passage from the intestinal lumen to themucosa
via M-cells, Shigella invades epithelial cells, triggering production
of proinflammatory cytokines and chemokines, resulting in strong
inflammation (PhaliponandSansonetti, 2007). Indeed, infection of
epithelial cells activates the cytoplasmic peptidoglycan sensors
Nod1 and 2,which stimulateNF-kB, themaster regulator of proin-
flammatory cytokine production (Girardin et al., 2003a, 2003b).
Moreover, infected epithelial cells secrete the endogenous
danger signal ATP as an early alert response acting upstream of
proinflammatory cytokines (Puhar et al., 2013). However, Shigella
has also evolved to control inflammation. To achieve this, the
bacteria have developed an array of strategies involving different
effectors encoded on their large virulence plasmid and delivered
by the type III secretion system (Phalipon and Sansonetti, 2007).
Many effectors prevent NF-kB activation by altering well-
described pathways such as ubiquitin-dependent protein degra-
dation and MAPK signaling. These effectors include OspG (Kim
et al., 2005), OspF (Arbibe et al., 2007; Li et al., 2007), IpaH9.8
(Ashida et al., 2007, 2010; Rohde et al., 2007), OspZ (Newton
et al., 2010), and OspI (Sanada et al., 2012). Shigella also modu-
lates inflammation by inhibition of host sphingosine-1-phosphate
levels (Kim et al., 2014). Recently, we showed that the effector
IpgD, through theproductionofPI5P, is able todampen inflamma-
tion through the inhibition of ATP secretion (Puhar et al., 2013).
Table 1. EGFR and ICAM-1 Internalization in HT-29 Infected with Shigella flexneri
Infection Time (min) 15 45
Strain DmxiD WT DipgD DmxiD WT DipgD
EGFR intern. 100 ± 13 164 ± 6* 120 ± 10 130 ± 10 193 ± 12* 102 ± 4
ICAM-1 intern. 118 ± 15 248 ± 11* 180 ± 19 132 ± 15 242 ± 21* 152 ± 19
HT-29 cells were grown on glass coverslips and infected for 15 or 45 min with the indicated Shigella strains. Internalization of each receptor in infected
cells is expressed as percentage with respect to internalized receptor in cells infected with the DmxiD mutant for 15 min. Results are expressed as
mean ± SEM and are representative of one experiment. Bonferroni’s multiple comparison test. *p < 0.05 as compared to DmxiD, 15-min infection.After infection, the inflammatory response is immediately initi-
ated by the activation of the innate immune system. Neutrophils
are the primary immune cells observed at sites of infection and
are involved in the pathogenesis of shigellosis in humans and
monkeys (Parsot and Sansonetti, 1996). In the rabbit ileal loop
model, Shigella infection is characterized by a massive recruit-
ment of neutrophils to the mucosa because of the production
of IL-8 by intestinal epithelial cells (Sansonetti et al., 1999). Neu-
trophils migrate across the epithelium, a process called transmi-
gration that involves several subsequent steps: adhesion to the
basolateral surface, crossing of the epithelial layer, and adhesion
to the apical side (Fournier and Parkos, 2012).
ICAM-1 (intercellular adhesion molecule-1) is a cell surface
glycoprotein member of the immunoglobulin superfamily that is
essential to cell-to-cell adhesion and activation of signaling path-
ways in response to inflammation (Lawson and Wolf, 2009).
ICAM-1 expression is increased in epithelial cells in response
to inflammatory cytokines such as interferon gamma and tumor
necrosis factor alpha (TNF-a) (Dippold et al., 1993). In patients
with inflammatory bowel disease and during bacterial infection,
a raise in expression of the receptor is also observed (Dippold
et al., 1993; Huang et al., 1996). In intestinal epithelial cells,
ICAM-1 is the major leukocyte receptor. Its expression is
restricted to the apical side (Huang et al., 1996), where it facili-
tates the adhesion of neutrophils that have reached the intestinal
lumen (Parkos et al., 1996). Engagement of ICAM-1 by the leuko-
cyte B2-integrins Mac-1 and LFA-1 triggers intracellular
signaling pathways (Holland and Owens, 1997), which are still
not fully characterized (Hubbard and Rothlein, 2000).
We have previously demonstrated that PI5P produced by IpgD
was able to trigger the internalization of the EGFR (Boal et al.,
2015; Ramel et al., 2011). It was therefore tempting to speculate
that Shigella could subvert the subcellular trafficking of cell sur-
face receptors involved in inflammation such as ICAM-1 to
escape the immune response. In this study, we show that IpgD
induces the internalization of ICAM-1 and directs it to the lyso-
somal degradation pathway in HT-29 colorectal epithelial cells.
ICAM-1 internalization to a late endosomal compartment is
PI5P dependent, as confirmed by the use of cell permeant lipids,
and does not involve the PI3-kinase pathway. In addition, we
demonstrate that PI5P reduces the adhesion of human neutro-
phils to epithelial cells in vitro. Finally, using the rabbit ileal loop
model ofShigella infection, we confirm that IpgD reduces neutro-
phil recruitment to the intestinal lumen. Altogether, our results
establish a mechanism of immune evasion involving the lipid
PI5P produced by the Shigella effector IpgD to control the cell
surface exposure of a receptor that is essential to the inflamma-
tory response.CRESULTS
Increased PI5P Levels Induce ICAM-1 Internalization
We previously demonstrated that in human epithelial HeLa cells
PI5P produced by IpgD expression induced EGF receptor acti-
vation, its internalization to early endosomes, and a sustained
activation of the PI3K-Akt survival pathway (Ramel et al.,
2011). We therefore explored whether the recycling of cell sur-
face receptors involved in inflammation pathways could also
be affected by IpgD, thereby strengthening the anti-inflamma-
tory effect of Shigella. To investigate whether Shigella infection
could induce ICAM-1 internalization in HT-29 cells, we condu-
cted a pilot experiment in which we infected the cells with
different Shigella strains and monitored its localization by immu-
nofluorescence on fixed cells. As a control, we quantified the
internalization of EGFR, which we previously demonstrated to
be internalized in an IpgD-dependent manner (Ramel et al.,
2011). The results, shown in Table 1, indicated that Shigella
infection induced EGFR internalization in HT-29 cells. Similarly,
in cells infected with the WT strain, we measured an increase
in ICAM-1 internalization. This internalization was neither
observed in cells infected with non-invasive mutant (DmxiD)
nor in cells infected with the ipgD-deficient strain (DipgD).
These results strongly suggested that ICAM-1 was internal-
ized in cells infected by Shigella through an IpgD-dependent
mechanism. In order to confirm this, we transiently expressed
GFP-IpgD in HT-29 cells. In GFP-expressing control cells,
ICAM-1 showed a plasmamembrane localization, with no or little
intracellular staining (Figures 1A and 1B, GFP panel). Strikingly,
in IpgD-expressing cells, ICAM-1 was internalized (Figures 1A
and 1B, IpgD panel). Overexpression of phosphatase-inactive
IpgD owing to a single point mutation at the catalytic site
(IpgD-CS) (Niebuhr et al., 2002) did not induce ICAM-1 internal-
ization (Figures 1A and 1B, IpgD-CS panel), suggesting that this
internalization could depend on PI5P synthesis. As a control,
ectopic expression of the heterologous phosphatase Inp54p,
known to transform PI(4,5)P2 into PI4P (Raucher et al., 2000),
was used. As shown in Figure S1, Inp54p expression had no ef-
fect on ICAM-1 localization, suggesting that PI5P synthesis
rather than changes in PI(4,5)P2 levels could account for
ICAM-1 internalization in IpgD-expressing cells.
ICAM-1 Is Internalized to the Endo-lysosomal
Compartment
To identify the subcellular compartment in which ICAM-1 was
localized following its internalization, we resorted to immunofluo-
rescence on fixed HT-29 cells. As shown in Figures 2A and 2B,
internalized ICAM-1 in IpgD-expressing cells did not co-localizeell Reports 14, 750–759, February 2, 2016 ª2016 The Authors 751
AB
Figure 1. IpgD Expression Induces ICAM-1 Internalization in HT29
Cells
(A) HT-29 cells were transiently transfected for GFP, GFP-IpgD, or GFP-IpgD-
CS and imaged by confocal microcoscopy for endogenous ICAM-1 localiza-
tion (red in merge). Scale bar represents 10 mm.
(B) Quantification of ICAM-1 internalization. Results are shown asmean ± SEM
from three independent experiments, representing from 42 to 78 cells. Bon-
ferroni’s multiple comparison test was used, and p value is indicated on the
graph.
See also Figure S1.withEEA1 (a bona fidemarker for early endosomes) orwithAPPL1
(amarker for signaling endosomes). In contrast, ICAM-1was inter-
nalized inaLAMP-2-positive compartment, as illustratedby the in-
crease in the Pearson’s coefficient (Figure 2B). Remarkably, IpgD
expression in HT-29 cells, which induced Akt activation through
EGFR (Figure S2A), resulted in EGFR accumulation in EEA1-pos-
itive early endosomes (Figures S2B–S2D), as we previously
described in other cell types (Boal et al., 2015; Ramel et al., 2011).
Similar to IpgD overexpression, we found that cells infected by
WT Shigella showed a dramatic internalization of ICAM-1 (Fig-752 Cell Reports 14, 750–759, February 2, 2016 ª2016 The Authorsure 2C), with an increase in co-localization with LAMP2 (Fig-
ure 2D). This phenomenon was dependent on the effector
IpgD, as shown by the lack of effect of the DipgD strain (Figures
2C and 2D).
Addition of short-chain cell permeant PI5P provided a quick
and synchronized stimulatory pulse that mimics IpgD overex-
pression (Boal et al., 2015; Ramel et al., 2011). We previously
showed that incubation of cells with cell-permeant PI5P
induced activation of the EGFR-PI3K-Akt signaling pathway in
HeLa cells (Pendaries et al., 2006; Ramel et al., 2011). In HT-
29 cells, incubation with short chain PI5P resulted in a marked
internalization of EGFR (Figure S3). Strikingly, treatment of
HT-29 cells with permeant PI5P, but not PI4P, resulted in the
internalization of ICAM-1 (Figures 3A, 3B, S4A, and S4B). Inter-
nalized ICAM-1 in PI5P-treated cells co-localized with the late
endosomal marker LAMP2 (Figure S4C). Furthermore, the use
of permeant PI5P allowed us to confirm ICAM-1 internalization
using an acid-wash removal of surface-bound anti-ICAM-1 an-
tibodies. Indeed, as shown in Figures 3C and 3D, a strong
signal for internalized ICAM-1 was observed in only PI5P-
treated cells.
Interestingly, EGFR did not co-localize with internalized
ICAM-1 in PI5P-treated cells (Figure 3E). This clearly demon-
strated that the two receptors were internalized to distinct pop-
ulations of endosomes, EGFR being internalized into an early
compartment (EEA1 positive), while ICAM-1 to a later compart-
ment (LAMP2 positive).
The fact that internalized ICAM-1 co-localized with the late en-
dosome/lysosome marker LAMP2 suggests that IpgD induced a
disappearance of ICAM-1 from the cell surface to the degrada-
tive pathway.
PI5P Induces ICAM-1 Degradation
In HT-29 cells, only very low transfection rates of IpgD could be
achieved (data not shown). For this reason, we used MEF cells
stably expressing IpgD under the control of an inducible Tet-
OFF promoter. In these cells, transiently overexpressed GFP-
ICAM-1 was internalized in a PI5P-dependent manner (Figures
4A and 4B). We then asked the question of whether ICAM-1
internalization was a specific event or a feature that could be
generalized to several other cell adhesion molecules or recep-
tors. To this end, we overexpressed GFP-fused endothelial-spe-
cific adhesion molecule VCAM-1 or the purinergic G-protein-
coupled receptor P2Y12. As shown in Figure 4C, IpgD expression
did not alter the plasma membrane localization of these recep-
tors, suggesting a selectivity in receptor endocytosis driven
by PI5P.
Next, we performed EM analysis of ICAM-1 localization in
MEF cells stably expressing IpgD versus control cells. Immuno-
gold labeling of cryosections showed that the majority of GFP-
ICAM-1 was found on intracellular vesicles in IpgD-expressing
cells (Figures 4D and 4E, ICV), while in control cells, it was
mainly found at the plasma membrane (Figures 4D and
4E, PM).
Finally, immunoblotting and quantification of GFP-ICAM-1
clearly demonstrated that it was degraded in IpgD-expressing
cells while no change in its mRNA level was observed (Figures
4F–4H). Moreover, treatment of cells with the lysosomal inhibitor
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Figure 2. IpgD-Induced ICAM-1 Internaliza-
tion to the Endo-Lysosomal System
(A) HT-29 cells expressing GFP-IpgD were imaged
by confocal microscopy with the indicated anti-
bodies. Scale bar represents 10 mm. See also
Figure S2.
(B) Quantification of co-localization between
ICAM-1 and indicated markers from (A).
(C) HT-29 cells were infected with WT Shigella, a
non-invasive strain (DmxiD) or the ipgD-deficient
strain (DipgD) for 15min, fixed and stained for
ICAM-1 (green), LAMP2 (red), and Shigella (blue).
Arrowheads indicate the presence of bacteria on
infected cells. Scale bar represents 10 mm.
(D) Quantification of co-localization between
ICAM-1 and LAMP2 in cells infected with the
indicated Shigella strains.bafilomycin A1 totally abrogated ICAM-1 degradation. Overall,
our results showed that PI5P produced by IpgD was responsible
for the internalization and degradation of the cell adhesion mole-
cule ICAM-1 in lysosomes.
PI5P Reduces Neutrophil Adhesion to HT-29 Cells
Cell-surface-exposed ICAM-1 binds to the leukocyte integrins
LFA-1 andMAC-1 (Lawson andWolf, 2009) and has been shown
to be involved in the recruitment of neutrophils to the site of infec-
tion (Huang et al., 1996). As PI5P induced ICAM-1 internalization
and degradation, we hypothesized that it could impact on the in-
flammatory response by reducing neutrophil recruitment. Using
purified human neutrophils stained with the viability dye
DiOC6(3) in a cell-cell adhesion assay, we showed that PI5P,
but not PI4P treatment, significantly reduced neutrophil adhe-
sion in a similar extent to the blocking anti-ICAM-1 antibody (Fig-
ures 5A and 5B).
IpgD-Dependent Transepithelial Migration of
Neutrophils In Vivo
In order to support our results in vivo, we infected rabbit ileal
loops with the WT Shigella strain and the ipgD-deficient strain.
We performed immunofluorescence stainings on fixed samples
of infected tissues. Cohesion of the epithelial lining was evalu-
ated based on the regular and linear position of DAPI-stained
nuclei. As shown in Figure 6A, ICAM-1 localization was alteredCell Reports 14, 750–759in infected epithelial cells in an IpgD-
dependent manner. Indeed, juxtanuclear
accumulation of ICAM-1 was only
observed after infection with the WT
strain but not with the ipgD-deficient
mutant, while no change in ICAM-1
expression levels was detected
(Table S1).
Next, we evaluated the transmigration
of neutrophils. As shown in Figure 6B, in
tissues infected by the WT strain, a large
amount of bacteria was seen on the sur-
face of the epithelium at this time of incu-
bation. In parallel, neutrophils remainedessentially located in the connective tissue of the villi lamina
propria. Few were seen associated to the epithelial lining and
the bacteria in the gut lumen. Conversely, in tissues infected
with the ipgD-deficient strain, bacteria were still at this stage
essentially located luminally on the epithelial surface, but neutro-
phils were largely seen associated with the epithelial lining and
mixed with bacteria in the lumen (Figure 6B, DipgD). Quantifica-
tion of neutrophil localization confirmed their inability to cross the
epithelial lining (Figure 6B, right).
Altogether, these results suggest that Shigella, through the in-
jection of IpgD, induces a decrease in neutrophil recruitment to
the apical side of the epithelial cells by reducing ICAM-1 cell sur-
face localization, ultimately leading to the inhibition of their
transmigration.
DISCUSSION
Taken together, our results demonstrate that the virulence factor
IpgD is able to alter the subcellular trafficking of the inflammatory
receptor ICAM-1 in Shigella-infected epithelial cells. High levels
of IpgD-produced PI5P are responsible for the internalization of
ICAM-1 and its subsequent degradation, reducing neutrophil
adhesion and providing the bacteria with a way to dampen im-
mune cell recruitment.
In this study, we show that high levels of PI5P induced
internalization of specific cell adhesion molecules (such as, February 2, 2016 ª2016 The Authors 753
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Figure 3. Intracellular Delivery of Short-Chain
PI5P but Not PI4P Induces ICAM-1 Internali-
zation to the Late Endosomes
(A) HT-29 cells were treated with 15 mM of permeant
PI4P or PI5P for 30min. PFA-fixed cells were stained
with an anti-ICAM-1 antibody (green in merge) and
anti-LAMP2 antibody (red in merge). Scale bar rep-
resents 10 mm.
(B) Quantification of internalized ICAM-1. Results
are shown as mean ± SEM from three independent
experiments. Bonferroni’s multiple comparison test
was used, and p value is indicated on the graph.
(C) HT-29 cells were surface-labeled with an anti-
ICAM-1 antibody for 30 min on ice and then incu-
bated at 37C for 30 min in the presence or not of
permeant PI5P. After acid-wash removal of surface-
bound antibodies, cells were fixed and stained for
internalized ICAM-1 (shown in red). In parallel, total
ICAM-1 was stained on permeabilized cells (shown
in green).
(D) Quantification of fluorescence intensity from (C)
depicting the amount of internalized ICAM-1 per
cell.
(E) Cells treated for 10 min with permeant PI5P and
fixed and stained for ICAM-1 (green in merge),
LAMP2 (red in merge), and EGFR (blue in merge).
Scale bar represents 5 mm.
See also Figures S3 and S4.ICAM-1 but not VCAM-1) or receptors (such as EGFR but
not P2Y12). This could be due to specific endocytic ma-
chineries activated by PI5P. To date, a broad variety of endo-
cytic routes has been described (Doherty and McMahon,
2009), in particular regarding ICAM-1 endocytosis (Stan,
2006). Engagement of ICAM-1 by leucocytes on endothelial
cells induces ICAM-1 clusterization and internalization in a
caveolin-1 dependent mechanism (Milla´n et al., 2006). Other
studies showed that ICAM-1 internalization induced by multi-
valent antibodies is molecularly distinct, involving dynamin-2
but not clathrin or caveolae (Muro et al., 2003, 2006). Using
selective inhibitors, we could rule out the involvement of the
EGFR-PIK3-Akt pathway as well as the GTPase dynamin in
PI5P-dependent ICAM-1 internalization (Figure S5). Therefore,
this process is molecularly distinct from the previously
described ICAM-1 internalization induced by nanoparticle-
coupled antibodies, called CAM-endocytosis (Muro et al.,
2003), and will require subsequent studies to be fully
characterized.754 Cell Reports 14, 750–759, February 2, 2016 ª2016 The AuthorsInterestingly, PI5P differentially medi-
ates the trafficking of EGFR and ICAM-1
in the very same cells. Indeed, while
elevated PI5P levels induce an accumula-
tion of EGFR in the early endosomes,
ICAM-1 traffics through a later compart-
ment and is ultimately degraded. This
discrepancy could be due to specificity
in cargo sorting from the endosomal
compartment. We recently demonstrated
that the endosomal protein TOM1 is en-riched on endosomes in IpgD-expressing cells and that this
accumulation is responsible for the stalling of EGFR (Boal
et al., 2015). However, although TOM1 accumulation blocks
EGFR trafficking in early endosomes, ICAM-1 is degraded in ly-
sosomes, indicating that a different effector may account for
ICAM-1 specific cargo sorting. Identification of this putative
effector will be of great interest to gain insight into the molec-
ular mechanisms involved in Shigella-induced ICAM-1
trafficking.
ICAM-1 is a key molecule mediating the recruitment of
neutrophil on the apical side of the epithelium. In our study,
we show that PI5P reduces neutrophil adhesion in vitro, while
in the in vivo intestinal loop model, we observed a dramatic
reduction in neutrophil transepithelial migration. Sumagin
et al. (2014) have demonstrated that engagement of epithelial
ICAM-1 at the apical face results in an increase in epithelium
permeability through the activation of the myosine light chain
kinase MLCK. Furthermore, Milla´n et al. (2006) have demon-
strated that neutrophil adhesion on the apical face will trigger
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Figure 4. IpgD Expression Induces ICAM-1
Internalization and Degradation
(A) Control MEF or MEF stably expressing IpgD,
IpgD-CS, or Inp54p and transiently expressing
GFP-ICAM-1 was fixed and imaged by confocal
microscopy for GFP fluorescence. Scale bar is
10 mm. Plasma membrane localization of GFP-
ICAM-1 is indicated by arrowheads.
(B) Quantification of ICAM-1 internalization from (A).
(C) The adhesion molecule VCAM-1 and the GPCR
P2Y12 were not internalized upon IpgD expression
in MEF cells. Plasma membrane localization is
indicated by arrowheads.
(D) Immunogold labeling of cryosections from MEF
cells expressing or not IpgD and transfected for
GFP-ICAM-1. Arrows highlight gold particles close
to the plasma membrane, while arrowheads depict
intracellular staining. PM, plasma membrane; ICV,
intracellular vesicles. Scale bar is 500 nm.
(E) Quantification of gold particles localization
from (D).
(F) Expression of GFP-ICAM-1 was assessed by
western blot in control MEF or MEF stably ex-
pressing IpgD after a 4-hr treatment with cyclo-
heximide and with or without bafilomycin A1.
(G) Quantification of GFP-ICAM-1 expression level
from (F). Results are from three to six independent
experiments and shown as mean ± SEM.
(H) mRNA levels for GFP-ICAM-1 in MEF cells were
unaffected by IpgD expression as shown by qPCR
analysis.the transcytosis of ICAM-1 to the basal face. Altogether, this
will facilitate subsequent neutrophil transmigration from the
basal to apical face of the epithelium. Our in vivo observations
are in line with these concepts, as adhesion to the apical face
and transmigration are intimately linked.
Shigella flexneri is using distinct and complex pathways to
dampen the host cell inflammatory response to its own advan-
tage. To achieve this, the bacteria combine the activity of
different effectors injected from the early stage of the infectious
process. These effectors essentially target the NF-kB pathway,
ultimately controlling the production of pro-inflammatory
cytokines (Arbibe et al., 2007; Ashida et al., 2007, 2010; Kim
et al., 2005; Li et al., 2007; Newton et al., 2010; Rohde et al.,
2007; Sanada et al., 2012). Shigella also modulates inflamma-
tion by inhibiting the host sphingosine-1-phosphate levels
providing the first example for the role of a lipid mediator in
regulating inflammation response (Kim et al., 2014). Strikingly,
in the case of IpgD, the same effector targets multiple
pathways to dampen the host inflammatory response during
infection. In addition to affecting T cell migration (Konradt
et al., 2011), we recently showed that IpgD, through the pro-
duction of PI5P blocks connexin-mediated secretion of the
endogenous danger signal ATP by epithelial cells, leading to
immune evasion (Puhar et al., 2013). In this paper, we unveil
a third way used by IpgD to dampen the inflammatoryCell Reports 14, 750–75response by targeting the cell surface
adhesion molecule ICAM-1 receptor,
thus making this phosphoinositide phos-phatase a bona fide meta-effector. Although blockade of
ICAM-1 with antibodies has been shown to be beneficial in
several inflammatory diseases, such as in polymicrobial sepsis
(Zhao et al., 2014) or in Crohn’s disease (in combination with
anti-VCAM-1 antibodies) (Burns et al., 2001), our study shows
that this defense mechanism is hijacked by Shigella for its
own benefit.
We describe here a bacterial strategy of evasion to immune
responses involving the direct alteration of the trafficking of
ICAM-1, thereby leading to its disappearance from the cell sur-
face. Such a mechanism has so far only been described in a
few cases of viral infection. For instance, a decrease of
ICAM-1 expression has been reported in keratinocytes after
infection by the varicella zoster virus (Nikkels et al., 2004), and
infection with the Kaposi sarcoma-associated herpes virus was
shown to lead to downregulation of ICAM-1 cell surface expres-
sion through an E3 ubiquitin ligase encoded by the virus (Brulois
et al., 2014; Tomescu et al., 2003).
In conclusion, we outline an original strategy used by the
bacteria to subvert the subcellular trafficking of the cell surface
adhesion molecule ICAM-1, thereby reducing the recruitment of
neutrophils, the primary immune cells recruited to site of inflam-
mation. Finally, our data reinforce the key role of the lipid medi-
ator PI5P in the control of several main cellular functions and
provide a potential new anti-inflammatory target.9, February 2, 2016 ª2016 The Authors 755
A B Figure 5. Cell-Permeant PI5P Treatment of
HT-29 Cells Reduces Adhesion of Human
Neutrophils
(A) Human neutrophils stained with DiOC6(3) were
left to adhere on HT-29 treated with the indicated
cell-permeant phosphoinositide (15 mM) or incu-
bated with an anti-ICAM-1 antibody (anti-ICAM-1).
Representative fluorescent images are shown.
Scale bar represents 200 mm.
(B) Quantification of neutrophils adhesion. Results
are expressed as percentage of the control, and
presented as mean ± SEM from four independent
experiments. Bonferroni’s multiple comparison
test was used, and p value is indicated on the
graph. ns, non-significant.EXPERIMENTAL PROCEDURES
Materials
Antibodies used in this study are as follows: anti-Akt (clone H-136, sc-8312,
Santa Cruz Biotechnology), anti-pAkt (S473; clone D9E, #4060, Cell Signaling),
anti-LAMP2 (ab13524, Abcam), anti-APPL1 (D83H4, Cell Signaling), anti-
pEGFR (Y1173; sc-12351-R, Santa Cruz Biotechnology), anti-Ly-6B.2 (AbD
Serotec). Antibodies against EGFR were from BD Biosciences (#555996) or
from Cell Signaling (clone D38B1, #4267). Mouse antibody against EEA1 was
from BD Biosciences (#610457); rabbit antibody against EEA1 was from
Enzo Life Sciences (#ALX-210-239-C100). Anti-ICAM-1 antibodies were from
Abcam (ab33090) or from Santa Cruz Biotechnology (sc-18853). Secondary
HRP-coupled antibodies were from Promega. Alexa Fluor-coupled antibodies
were from Life Technologies. The peGFP-N1-ICAM-1 and VCAM-1were kindly
provided by Dr. Francisco Sanchez-Madrid (CNIC) and was as described (Bar-
reiro et al., 2002). P2Y12-GFP plasmidwas provided byDr. Veronique Pons and
was as described (Pons et al., 2014). Other chemicals were from Sigma-
Aldrich. qRT-PCR analysis was performed as described (Boal et al., 2015).
Cell Culture, Transfections, and Induction of ICAM-1 Expression
The human colorectal epithelial cell line HT-29 and MEF cells were grown in
DMEM (#31966-021, Life Technologies) supplemented with 10% fetal bovine
serum (FBS). ICAM-1 expression was induced by stimulation with TNF-a
(50 ng/ml) overnight. HT-29 cells were transfected using jetPRIME (Polyplus
transfection) according tomanufacturer’s instructions.When needed, the cells
were serum starved for at least 3 hr before being processed.Mouse embryonic
fibroblast (MEF) cells stably expressing IpgD under the control of a Tet-OFF
promoter were as described (Boal et al., 2015).
Immunofluorescence and Quantification of Internalization of EGFR
or ICAM-1
Immunofluorescence was performed essentially as described (Boal et al.,
2010). Briefly, cells grown on glass coverslips were PFA fixed, followed by per-
meabilization with 0.1%Triton X-100 in PBS for 5min, blocked using PBS con-
taining 1% BSA (PBS-BSA) and probed with primary antibodies followed by
secondary antibodies. Coverslips were mounted in Mowiol and imaged by
confocal microscopy on a LSM510 or LSM780 confocal microscope (Zeiss),
and the imaging parameters were set to prevent any saturation of the signals.
For co-localization studies, Pearson’s coefficient was calculated using the Co-
localization Threshold plugin in ImageJ. For quantification of internalized EGFR
or ICAM-1, an outer ring just surrounding the cell was drawn, which yielded the
total fluorescence intensity, i.e., the total amount of EGFR or ICAM-1 ex-
pressed in the cell. An inner ring just below the plasma membrane was then
drawn, which yielded the amount of EGFR or ICAM-1 internalized into the
cell. The ratio between the two values gave the amount of internalized EGFR
or ICAM-1, normalized against the total amount of receptor expressed in the
cell and was expressed as percentage of the control.
Western Blotting
Typically, cells were washed in ice-cold PBS and lysed in buffer (50 mM Tris
[pH 7.5], 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM orthovanadate756 Cell Reports 14, 750–759, February 2, 2016 ª2016 The Authorssodium, 50 mM beta-glycero phosphate, protease inhibitor Cocktail Set V;
Calbiochem) for 30 min on ice. Cell lysates were clarified by centrifugation at
10,000 3 g for 10 min at 4C and quantified using Bio-Rad protein assay.
Lysates were denaturated in Laemmli sample buffer, and proteins were sepa-
rated by SDS-PAGE before western blotting on Immobilon-P membranes
(Merck-Millipore). Immunoreactive bands were detected by chemilumines-
cence with the SuperSignal West Pico detection system (Thermo Scientific)
on a ChemiDoc MP acquisition system (Bio-Rad). To detect ICAM-1 by
western blot, samples were specifically resuspended in DTT-free Laemmli
buffer.
Short-Chain Cell Permeant Phosphoinositides Treatments and
Internalization Assay
HT-29 cells grown on glass coverslips were incubated with 15 mM C4-PI4P or
C4-PI5P (Echelon Biosciences) for the indicated times as previously described
(Pendaries et al., 2006; Ramel et al., 2011) before being processed for immu-
nofluorescence or western blot. For internalization assay, cells were surface
labeled with an anti-ICAM-1 antibody for 30 min at 4C and washed with
ice-cold PBS. Internalization of bound antibodies was performed at 37C for
30 min in the presence or not of permeant PI5P. Surface-bound antibodies
were stripped by acid wash (25 mM glycine, 3% BSA in PBS [pH 3]) for
10 min on ice. After extensive washes, the cells were PFA fixed, stained with
a fluorescent anti-mouse antibody, and imaged by confocal microscopy.
In Vitro Neutrophil Adhesion Assay
Neutrophil adhesion assays were essentially performed as described else-
where (Huang et al., 1996). Briefly, buffy coat obtained from healthy donors
was mixed with an equal volume of 6% dextran-500 in PBS and incubated
at room temperature for 40 min. The top layer (leukocyte rich plasma) was
then recovered, and cells were washed in PBS. Residual erythrocytes were
lysed by a 5-min incubation at room temperature in ACK lysis buffer (0.15 M
NH4Cl, 1 mM KHCO3, 0.1 mM EDTA [pH 7.3]). After washing, the remaining
white blood cells were layered on Ficoll-Plaque Plus (GE Healthcare) and
centrifuged for 40 min at 400 3 g at room temperature. The pellet was har-
vested, and obtained neutrophils were washed in PBS. Neutrophils were
stained with the viability dye DiOC6(3) (Life Technologies) for 10 min at 37C
at 500 nM.
For adhesion assays, HT-29 cells grown to confluency in 48-well plates were
stimulated overnight with TNF-a (50 ng/ml) and treated accordingly with per-
meant C4-PI4P or C4-PI5P for 30 min at 37C. Alternatively, cells were treated
with 10 ml per well of the blocking anti-ICAM-1 antibody (ab33090) for the same
time. Stained neutrophils were then added (90,000 cells per well), and the plate
was centrifuged at room temperature for 5 min at 50 3 g. After incubation for
10min at 37C, the cells were extensively washed in PBS, and live cell imaging
was performed to visualize adherent neutrophils. For quantifications, three
random fields of view were imaged using a wide-field fluorescent microscope
equippedwith a 43 lens. Same imaging parameters were used to compare the
different conditions. After thresholding, the mean fluorescence intensity per
field of view was quantified using ImageJ, and results were expressed as
mean ± SEM from four independent experiments and presented as a percent-
age of the untreated control.
AB
Figure 6. ICAM-1 Localization and Reduc-
tion of Neutrophil Transmigration in Rabbit
Ligated Ileal Loop Infected with Shigella Is
IpgD Dependent
(A) Rabbit-ligated ileal loops were infected withWT
Shigella, a non-invasive strain (DmxiD), or the
ipgD-deficient strain (DipgD) for 7 hr. Sections
were stained for ICAM-1 (red) and Shigella (green).
Nuclei were stained with DAPI (blue). Arrows
point to juxtanuclear accumulation of ICAM-1 in
infected cells. Scale bar represents 10 mm. See
also Table S1.
(B) Infected ileal loops were stained for neutrophils
(red) and Shigella (green). Nuclei were stained with
DAPI (blue). Zoomed boxes are shown in the bot-
tom panels. Neutrophils accumulation in the
interstitial spaces is only observed in ileal loops
infected with the WT Shigella (arrow). (Right) The
quantification of neutrophils present in the luminal
space versus lamina propria (mean ± SD). See
also Table S1.Shigella Flexneri Strains and In Vitro and In Vivo Infections
The WT Shigella flexneri serotype 5a strain M90T, the non-invasive DmxiD
mutant and the DipgD mutant were described previously (Puhar et al., 2013).
Infections of rabbit ileal loops or HT-29 cells were also performed as described
(Puhar et al., 2013). Analysis of ICAM-1 expression from ligated ileal loops was
performed as described (Puhar et al., 2013). Primers used are as follows:
50-AACTCTTGACTTGGATGTATT-30 (sense) and 50-GCAGGAACCTACTC
TACT-30 (antisense).
Immunofluorescence on Paraffin-Embedded Sections
Paraffin-embedded ileal loop sections were deparaffinized and rehydrated,
and antigen retrieval was performed using a sodium citrate treatment
(15-min incubation in a 70C water bath). For ICAM-1 staining, a gentler so-
dium citrate treatment was performed (2-min incubation in a 70C hot water
bath). Permeabilization was performed with 0.2% Triton X-100 for 20 min.
After blocking of nonspecific sites with 1% BSA, the primary antibodies
were incubated overnight at 4C. After labeling with appropriate secondary
antibodies, the sections were mounted in Vectashield mounting medium,
including DAPI (Vector Laboratories), and imaged by epifluorescence
microscopy.
Immunoelectron Microscopy
For immunoelectron microscopy, samples were fixed with a mixture of 2%
PFA and 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Cells were
scraped, pelleted, and embedded in 10% bovine skin gelatin in 0.1 M phos-
phate buffer. Fragments of the pellet were infiltrated overnight with 2.3 M
sucrose in 0.1 M phosphate buffer at 4C, mounted on aluminum studs, and
frozen in liquid nitrogen. Sectioning was done at 120C in a cryoultramicro-
tome (UC7/FC7 Leica Microsystems). The 80-nm ultrathin sections were
collected in 1:1 mixture of 2.3 M sucrose and 2% methyl cellulose and trans-
ferred onto Formvar-carbon-coated nickel grids for immunogold localization.
Cells were immunolabeled with anti-ICAM-1 and immunogold-labeled using
10 nm protein A-gold particles. Grids were then stained with a mixture of
2% methylcellulose and 0.4% uranyl acetate. Samples were analyzed with a
TEM (Jeol JEM-1400, JEOL) at 80 kV. Images were acquired using a digital
camera (Gatan Orius, Gatan) at 10,0003 magnification.
Statistical Analysis
Statistical analysis was performed using the unpaired Student’s t test for com-
parison between two groups. Formulti-group comparison, an ANOVA test was
performed followed by a Bonferroni’s post hoc test. Results are presented asCmean ± SEM unless otherwise stated, and p values considered significant are
indicated in the figure legends.
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